Verastem Oncology
VSTM
#6412
Rank
ยฃ0.58 B
Marketcap
ยฃ7.78
Share price
-2.26%
Change (1 day)
89.00%
Change (1 year)

Revenue for Verastem Oncology (VSTM)

Revenue in 2025 (TTM): ยฃ9.91 Million

According to Verastem Oncology 's latest financial reports the company's current revenue (TTM ) is ยฃ10.04 Million. In 2024 the company made a revenue of ยฃ7.96 Million an increase over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Verastem Oncology from 2011 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ9.91 M24.47%
2024 ยฃ7.96 M
2023 N/A-100%
2022 ยฃ2.14 M41.09%
2021 ยฃ1.52 M-97.66%
2020 ยฃ64.93 M387.85%
2019 ยฃ13.31 M-36.76%
2018 ยฃ21.04 M
2017 N/A
2016 N/A
2015 N/A
2014 N/A
2013 N/A
2012 N/A
2011 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Curis
CRIS
ยฃ8.74 M-12.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ47.13 B 469,187.69%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
ยฃ10.33 B 102,787.36%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
ยฃ31.79 B 316,461.61%๐Ÿ‡ฌ๐Ÿ‡ง UK